MedTrace Logo

Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival

NCT02055313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-02-25

No results posted yet for this study

Summary

The main objective of this study is to explore experiences and insights from exceptional patients, patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state.

A secondary future objective of this study is to develop an international multicenter registry and database documenting and examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state.

Conditions

Sponsors & Collaborators

  • Clalit Health Services

    collaborator OTHER

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Moshe A Frenkel, MD · Clalit Health Services

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2020-10-31
Completion
2020-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02055313 on ClinicalTrials.gov